Connor, Clark & Lunn Investment Management »

BioCryst Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.2M 682k 7.60
2024-06-30 $4.8M 783k 6.18
2024-03-31 $3.7M 719k 5.08
2023-12-31 $4.1M 692k 5.99
2023-09-30 $3.8M 543k 7.08
2023-06-30 $2.8M 401k 7.04
2023-03-31 $2.9M 348k 8.34
2022-12-31 $319k 28k 11.48
2022-03-31 $1.5M 92k 16.26
2021-06-30 $764k 48k 15.80
2020-03-31 $1.2M 612k 2.00
2019-12-31 $612k 178k 3.45
2018-03-31 $78k 16k 4.80
2017-12-31 $184k 38k 4.90
2017-09-30 $256k 49k 5.24
2016-06-30 $378k 133k 2.84
2016-03-31 $570k 202k 2.83
2015-12-31 $2.1M 207k 10.32
2015-09-30 $2.7M 238k 11.40
2015-06-30 $1.4M 91k 14.93
2015-03-31 $1.5M 161k 9.03
2014-12-31 $3.0M 213k 14.08
2014-09-30 $1.9M 169k 10.93
2014-06-30 $2.0M 149k 13.58
2014-03-31 $6.2M 528k 11.68